Metraipolis › archive › dc_ebdfeee0fadc

Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress — Europe PMC PMID:41113763

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41113763
DOI
10.37349/etat.2025.1002339
License (as archived)
solo-consultazione
Archived
2026-11-09T09:36:00.358Z
SHA-256 of the archived text
3b3a87023ec5e032a24f27eea0f3f1f3c3f97e7017e9c669743b4a28546f392a
Stable URL of this page
https://metraipolis.com/documento/dc_ebdfeee0fadc

How to cite

Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress — Europe PMC PMID:41113763 — Europe PMC (en), https://europepmc.org/article/MED/41113763 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebdfeee0fadc (Metraipolis archive dc_ebdfeee0fadc, sha256 3b3a87023ec5e032a24f27eea0f3f1f3c3f97e7017e9c669743b4a28546f392a)
BibTeX
@misc{dcebdfeee0fadc,
  title = {Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress — Europe PMC PMID:41113763},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41113763},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebdfeee0fadc; sha256 3b3a87023ec5e032a24f27eea0f3f1f3c3f97e7017e9c669743b4a28546f392a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41113763. Agents can read the archived copy with the MCP tool read_document.